Skip to main content
OSTI.GOVU.S. Department of Energy Office of Scientific and Technical Information
U.S. Department of Energy
Office of Scientific and Technical Information
 

Human Immunodeficiency Virus type 1 group M consensus and mosaic envelope glycoproteins

Patent ·
OSTI ID:1410329
; ; ; ; ;

The disclosure relates to nucleic acids mosaic clade M HIV-1 Env polypeptides and to compositions and vectors comprising same. The nucleic acids are suitable for use in inducing an immune response to HIV-1 in a human.

Research Organization:
Los Alamos National Laboratory (LANL), Los Alamos, NM (United States)
Sponsoring Organization:
USDOE
DOE Contract Number:
AC52-06NA25396
Assignee:
Duke University (Durham, NC); Los Alamos National Security, LLC (Los Alamos, NM); The UAB Research Foundation (Birmingham, AL); Beth Israel Deaconess Medical Center (Boston, MA)
Patent Number(s):
9,821,053
Application Number:
14/689,995
OSTI ID:
1410329
Country of Publication:
United States
Language:
English

References (54)

Replicating Ad-recombinants encoding non-myristoylated rather than wild-type HIV Nef elicit enhanced cellular immunity journal January 2006
Control of Viremia and Prevention of Clinical AIDS in Rhesus Monkeys by Cytokine-Augmented DNA Vaccination journal October 2000
A New Variant Cytotoxic T Lymphocyte Escape Mutation in HLA-B27-Positive Individuals Infected with HIV Type 1 journal May 2005
Characterization and Selection of HIV-1 Subtype C Isolates for Use in Vaccine Development journal February 2003
Clonal breadth of the HIV-1-specific T-cell receptor repertoire in vivo as determined by subtractive analysis journal January 2005
Polygene DNA vaccine induces a high level of protective effect against HIV-vaccinia virus challenge in mice journal September 2004
Diversity Considerations in HIV-1 Vaccine Selection journal June 2002
Antigenicity and Immunogenicity of a Synthetic Human Immunodeficiency Virus Type 1 Group M Consensus Envelope Glycoprotein journal December 2004
Use of T Cell Epitopes for Vaccine Development journal November 2001
The end or the beginning of the drive to an HIV-preventive vaccine: a view from over 20 years journal September 2005
HIV-1 superinfection despite broad CD8+ T-cell responses containing replication of the primary virus journal November 2002
Cross-Subtype T-Cell Immune Responses Induced by a Human Immunodeficiency Virus Type 1 Group M Consensus Env Immunogen journal June 2006
HIV vaccine strategies journal February 2002
Aiming to induce broadly reactive neutralizing antibody responses with HIV-1 vaccine candidates journal January 2014
Viral Escape from Dominant Simian Immunodeficiency Virus Epitope-Specific Cytotoxic T Lymphocytes in DNA-Vaccinated Rhesus Monkeys journal July 2003
Improved Vaccine Protection from Simian AIDS by the Addition of Nonstructural Simian Immunodeficiency Virus Genes journal December 2005
Identification of Highly Conserved and Broadly Cross-Reactive HIV Type 1 Cytotoxic T Lymphocyte Epitopes as Candidate Immunogens for Inclusion in Mycobacterium bovis BCG-Vectored HIV Vaccines journal September 2000
The Role of T Cell Antagonism and Original Antigenic Sin in Genetic Immunization journal December 2002
Control of Viremia in Simian Immunodeficiency Virus Infection by CD8+ Lymphocytes journal February 1999
Codon usage limitation in the expression of HIV-1 envelope glycoprotein journal March 1996
HIV‐Specific Cellular Immune Response Is Inversely Correlated with Disease Progression as Defined by Decline of CD4+ T Cells in Relation to HIV RNA Load
  • Oxenius, Annette; Price, David A.; Hersberger, Martin
  • The Journal of Infectious Diseases, Vol. 189, Issue 7, p. 1199-1208 https://doi.org/10.1086/382028
journal April 2004
HIV VACCINES journal December 2005
Consistent Cytotoxic-T-Lymphocyte Targeting of Immunodominant Regions in Human Immunodeficiency Virus across Multiple Ethnicities journal February 2004
HIV-1 Nef Downregulates MHC-I by a PACS-1- and PI3K-Regulated ARF6 Endocytic Pathway journal December 2002
HIV-1 Viral Escape in Infancy Followed by Emergence of a Variant-Specific CTL Response journal June 2005
Enhanced Detection of Human Immunodeficiency Virus Type 1-Specific T-Cell Responses to Highly Variable Regions by Using Peptides Based on Autologous Virus Sequences journal July 2003
Urgently needed: a filter for the HIV-1 vaccine pipeline journal August 2004
CD8+ T Cell Epitope-Flanking Mutations Disrupt Proteasomal Processing of HIV-1 Nef journal September 2005
Human Immunodeficiency Virus Type 1 Subtype B Ancestral Envelope Protein Is Functional and Elicits Neutralizing Antibodies in Rabbits Similar to Those Elicited by a Circulating Subtype B Envelope journal August 2005
Glycosylation Site-Specific Analysis of Clade C HIV-1 Envelope Proteins journal September 2009
Clustering Patterns of Cytotoxic T-Lymphocyte Epitopes in Human Immunodeficiency Virus Type 1 (HIV-1) Proteins Reveal Imprints of Immune Evasion on HIV-1 Global Variation journal September 2002
Fine Specificity and Cross-Clade Reactivity of HIV Type 1 Gag-Specific CD4+ T Cells journal March 2004
Polyvalent vaccines for optimal coverage of potential T-cell epitopes in global HIV-1 variants journal December 2006
Prospects for an AIDS vaccine journal March 2004
Initial B-Cell Responses to Transmitted Human Immunodeficiency Virus Type 1: Virion-Binding Immunoglobulin M (IgM) and IgG Antibodies Followed by Plasma Anti-gp41 Antibodies with Ineffective Control of Initial Viremia journal October 2008
Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA journal December 2004
Evolutionary and immunological implications of contemporary HIV-1 variation journal September 2001
Recombination in HIV-1 journal March 1995
A group M consensus envelope glycoprotein induces antibodies that neutralize subsets of subtype B and C HIV-1 primary viruses journal September 2006
De Novo Generation of Escape Variant-Specific CD8+ T-Cell Responses following Cytotoxic T-Lymphocyte Escape in Chronic Human Immunodeficiency Virus Type 1 Infection journal September 2005
DNA multi-CTL epitope vaccines for HIV and Plasmodium falciparum: immunogenicity in mice journal February 1998
T-Cell Vaccine Strategies for Human Immunodeficiency Virus, the Virus with a Thousand Faces journal May 2009
Immunogenicity of Multiple Gene and Clade Human Immunodeficiency Virus Type 1 DNA Vaccines journal November 2003
Expanded Breadth of the T-Cell Response to Mosaic Human Immunodeficiency Virus Type 1 Envelope DNA Vaccination journal December 2008
Mosaic vaccines elicit CD8+ T lymphocyte responses that confer enhanced immune coverage of diverse HIV strains in monkeys journal February 2010
Mosaic HIV-1 vaccines expand the breadth and depth of cellular immune responses in rhesus monkeys journal February 2010
Determinants of Human Immunodeficiency Virus Type 1 Escape from the Primary CD8+ Cytotoxic T Lymphocyte Response journal November 2004
Hierarchical Targeting of Subtype C Human Immunodeficiency Virus Type 1 Proteins by CD8+ T Cells: Correlation with Viral Load journal March 2004
HIV-1 Nef is preferentially recognized by CD8 T cells in primary HIV-1 infection despite a relatively high degree of genetic diversity journal January 2004
T Cell Cross-Reactivity and Conformational Changes during TCR Engagement journal December 2004
Multiclade Human Immunodeficiency Virus Type 1 Envelope Immunogens Elicit Broad Cellular and Humoral Immunity in Rhesus Monkeys journal February 2005
A centralized gene-based HIV-1 vaccine elicits broad cross-clade cellular immune responses in rhesus monkeys journal July 2008
Toward an AIDS Vaccine journal May 2008
Human Immunodeficiency Virus-Specific Responses in Adult Ugandans: Patterns of Cross-Clade Recognition journal March 2005

Similar Records

Related Subjects

59 BASIC BIOLOGICAL SCIENCES
60 APPLIED LIFE SCIENCES